Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Guggenheim Downgrades Surrozen to Neutral

Guggenheim Downgrades Surrozen to Neutral

Guggenheim analyst Yatin Suneja downgrades Surrozen (NASDAQ:SRZN) from Buy to Neutral.

byBenzinga Newsdesk

November 18, 2022

1 minute read

Guggenheim analyst Yatin Suneja downgrades Surrozen (NASDAQ:SRZN) from Buy to Neutral.

BMO Capital Maintains Outperform on Paysafe, Lowers Price Target to $80

By Benzinga Newsdesk

March 10, 8:47 AM

BMO Capital analyst James Fotheringham maintains Paysafe (NYSE:PSFE) with a Outperform and lowers the price target from $84 to $80.

PSFE

Movers
News

Why Calidi Biotherapeutics is Moving Higher Monday

By Dylan Berman

June 10, 10:53 AM

Calidi and SIGA are partnering in order to advance Calidi's RTNova virotherapy for lung cancer and metastatic solid tumors.

CLDI

The Hartford Financial Services Group Increased Quarterly Common Dividend Per Share By 10% From $0.385 To $0.425 Per Share

By Benzinga Newsdesk

October 27, 4:46 PM

Returned $476 million to stockholders in the quarter, including $350 million of shares repurchased and $126 million in common stockholder dividends paid. Increased the quarterly common

HIG

First Bancshares Q3 Adj. EPS $0.85 Up From $0.76 YoY, Sales $49.15M Up From $40.03M YoY

By Michael Horton

October 27, 5:18 PM

First Bancshares (NASDAQ:FBMS) reported quarterly earnings of $0.85 per share. This is a 11.84 percent increase over earnings of $0.76 per share from the same period last year. The company reported $49.15 million in

FBMS

Guggenheim Downgrades Surrozen to Neutral

Related Posts

BMO Capital Maintains Outperform on Paysafe, Lowers Price Target to $80

Why Calidi Biotherapeutics is Moving Higher Monday

The Hartford Financial Services Group Increased Quarterly Common Dividend Per Share By 10% From $0.385 To $0.425 Per Share

First Bancshares Q3 Adj. EPS $0.85 Up From $0.76 YoY, Sales $49.15M Up From $40.03M YoY